Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFenner PLC Regulatory News (FENR)

  • There is currently no data for FENR

Acquisition

2 Feb 2015 07:00

RNS Number : 6949D
Fenner PLC
02 February 2015
 

02 February 2015

Fenner PLC ("Fenner")

Acquisition of Charter Medical Limited ("Charter")

Fenner is pleased to announce that its wholly owned subsidiary Fenner Drives, Inc. has acquired 100% of the share capital of Charter from its parent company Lydall, Inc. a publicly traded company (NYSE: LDL) headquartered in Connecticut. Charter will be integrated into Solesis Medical Technologies ("Solesis"), part of Fenner's AEP division.

The consideration of US$29.9m was satisfied in cash at completion and the transaction is expected to be earnings enhancing immediately upon acquisition.

Charter manufactures specialty single-use assemblies and Class I and Class II medical devices for the collection, processing, storage and filtration of biological and bioprocessing fluids. Charter also produces bio-containers and fluid management sets that serve a range of life science applications including biopharmaceutical manufacturing, cell therapy and cryogenic storage. Charter is a single site company based in Winston-Salem, North Carolina.

As at 31 December 2014, unaudited gross assets acquired were US$6.9m with underlying EBITDA (1) of US$3.3m for the 12 months to 31 December 2014 on sales of US$19.6m. 

The entire workforce of Charter have become employees of Fenner upon completion and will continue to be led by General Manager, Mr. Gael Peron.

Nick Hobson, CEO of Fenner PLC, commented:

"In common with all businesses in our AEP division, Charter applies its polymer technology to solving problems in performance-critical applications. Charter has a strong, established business in blood transfusion and filtration markets and has exciting opportunities in the bio-processing and regenerative medicine markets, in which Fenner is already active and which are experiencing rapid growth. 

The acquisition of Charter, which will provide an attractive addition to the capabilities and offerings of Solesis, continues Fenner's strategy to develop our medical business both organically and by acquisition."

For further information please contact:

 

Fenner PLC 01482 626501

Nick Hobson, Chief Executive

John Pratt, Finance Director

 

Weber Shandwick Financial 020 7067 0700

Nick Oborne / Tom Jenkins

 

 

(1) Adjusted for historic non-recurring items

 

Notes to editors:

 

Fenner PLC is a world leader in reinforced polymer technology, providing local engineered solutions for performance-critical applications. The Group operates through two divisions:

Engineered Conveyor Solutions: the ECS division, trading under the Fenner Dunlop, Fenner and Dunlop brand names, is a recognised leader in the global conveying market. The division offers a unique, comprehensive suite of products and services, which serve the conveying needs of mining, power generation and bulk handling markets.

Advanced Engineered Products: the AEP division uses advanced polymeric materials and technical expertise to provide high value-added solutions to customers' most challenging engineering problems. Customers are spread across a variety of end-user segments, including oil & gas and medical which account for some 40 per cent of divisional revenue, together with construction, transportation, automation and general industrial. AEP's trading names are recognised globally and include CDI Energy Products, EGC Critical Components, Hallite, AIP Precision Machining, Fenner Precision, Fenner Drives, James Dawson, Mandals, Secant Medical and Xeridiem.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
ACQUARWRVBAURAR
Date   Source Headline
7th May 201310:47 amRNSHolding(s) in Company
3rd May 20139:07 amRNSDirector/PDMR Shareholding
2nd May 20133:46 pmRNSDirector/PDMR Shareholding
2nd May 20133:24 pmRNSDirector/PDMR Shareholding
2nd May 201310:39 amRNSDirector/PDMR Shareholding
1st May 20139:31 amRNSDirector/PDMR Shareholding
29th Apr 201311:58 amRNSHolding(s) in Company
24th Apr 20137:00 amRNSHalf Year Results
27th Mar 20132:41 pmRNSHolding(s) in Company
7th Mar 20137:00 amRNSPre-Close Trading Statement
4th Mar 20132:35 pmRNSBlocklisting Interim Review
22nd Jan 201311:04 amRNSResult of AGM
18th Jan 20134:10 pmRNSDirector/PDMR Shareholding
16th Jan 20137:00 amRNSAGM and IMS
11th Jan 20139:13 amRNSAnnual Information Update
9th Jan 20139:02 amRNSHolding(s) in Company
27th Dec 20127:00 amRNSHolding(s) in Company
14th Dec 20123:12 pmRNSHolding(s) in Company
13th Dec 201212:05 pmRNSDocuments available for Inspection/Notice of AGM
6th Dec 20122:16 pmRNSDirector/PDMR Shareholding
6th Dec 20129:34 amRNSHolding(s) in Company
30th Nov 20129:55 amRNSTotal Voting Rights
23rd Nov 20124:08 pmRNSDirector/PDMR Shareholding
20th Nov 20124:43 pmRNSAdditional Listing
19th Nov 20129:07 amRNSHolding(s) in Company
16th Nov 20123:17 pmRNSDirector/PDMR Shareholding
7th Nov 20127:00 amRNSFinal Results
26th Oct 20127:00 amRNSAcquisition of Australian Conveyor Engineering
15th Oct 20123:26 pmRNSHolding(s) in Company
5th Oct 20123:06 pmRNSHolding(s) in Company
10th Sep 20127:00 amRNSPre Close Statement
3rd Sep 201211:18 amRNSBlocklisting Interim Review
10th Aug 20127:00 amRNSAcquisition
9th Aug 20122:57 pmRNSAcquisition
7th Aug 20122:18 pmRNSAcquisition
23rd Jul 20129:10 amRNSHolding(s) in Company
12th Jul 20127:00 amRNSInterim Management Statement
11th Jul 20122:22 pmRNSHolding(s) in Company
29th Jun 20127:00 amRNSAppointment of Joint Corporate Broker
20th Jun 201212:30 pmRNSHolding(s) in Company
6th Jun 20124:03 pmRNSDirector/PDMR Shareholding
17th May 20124:47 pmRNSHolding(s) in Company
30th Apr 201210:19 amRNSHolding(s) in Company
26th Apr 20122:53 pmRNSDirector/PDMR Shareholding
26th Apr 201210:31 amRNSDirector/PDMR Shareholding
25th Apr 20127:00 amRNSHalf Year Results
3rd Apr 20121:03 pmRNSHolding(s) in Company
27th Mar 201211:57 amRNSHolding(s) in Company
13th Mar 20123:25 pmRNSHolding(s) in Company
8th Mar 20127:00 amRNSPre-Close Trading Statement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.